Conditions: Asthma (Part 1); COPD (Part 2)
Interventions: Drug: Dose 1, AZD8871 50 ?g (Part 1); Drug: Dose 2, AZD8871 100 ?g (Part 1); Drug: Dose 3, AZD8871 300 ?g (Part 1); Drug: Dose 4, AZD8871 600 µg (Part 1); Drug: Dose 5, AZD8871 1200 µg (Part 1); Drug: Dose 6, AZD8871 1800 ?g (Part 1); Drug: Placebo, AZD8871 placebo (Part 1); Drug: Treatment A, AZD8871 dose A (Part 2); Drug: Treatment B, AZD8871 dose B (Part 2); Drug: Treatment C, Indacaterol 150 ?g (Part 2); Drug: Treatment D, Tiotropium 18 ?g (Part 2)
Sponsor: AstraZeneca
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days